Pediatrics Doctors in Iowa Medicare Details, Address, Contact

766 Pediatrics doctors found. Showing 201 - 220

Dr. Abigail Harmon Allard, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1801 Hickman Rd, Des Moines, IA 50314 Phone: 515-282-2200

Dr. Melodee Sue Woodard, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 535 Sw 7th St, Des Moines, IA 50309 Phone: 515-725-0831

Aaron C. Mcclure, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 1111 6th Ave, Main 3, Des Moines, IA 50314 Phone: 515-643-8677    Fax: 515-643-8316

William E Howard Iv, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 330 Laurel St, Suite 2100, Des Moines, IA 50314 Phone: 515-643-8611

Mustafa Eldadah, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 330 Laurel St, Suite 2100, Des Moines, IA 50314 Phone: 515-643-8611    Fax: 515-643-8812

Dr. Matthew Gary Petty, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1111 6th Avenue, Main 3, Des Moines, IA 50314 Phone: 515-246-9320    Fax: 515-643-8966

Susan M Harrell, MD Pediatrics - Neonatal-Perinatal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 Pleasant St, Neonatology, Des Moines, IA 50309 Phone: 515-241-5926    Fax: 515-241-5127

Teresa Patricia Monsod Borromeo, MD Pediatrics - Pediatric Endocrinology Medicare: Medicare Enrolled Practice Location: 1215 Pleasant St, Suite 300, Des Moines, IA 50309 Phone: 515-241-6500    Fax: 515-241-8911

William M Salow, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 330 Laurel St, Suite 2100, Des Moines, IA 50314 Phone: 515-643-8611    Fax: 515-643-8812

Samantha L. Mallory, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St Ste 514, Des Moines, IA 50309 Phone: 515-241-8912    Fax: 515-241-8988

Christina Marie Dasilva, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-5008

Nadejda Dergham Tawfiq Baklizi, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 Pleasant St # B5, Des Moines, IA 50309 Phone: 515-241-4497

Lisa J Menzies, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1212 Pleasant St, Suite 300, Des Moines, IA 50309 Phone: 515-241-8923    Fax: 515-241-5127

Dr. Jessica Caitlin Barry, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 Pleasant St # B5, Des Moines, IA 50309 Phone: 515-241-4497

Dr. Ranjani Ananth, MD Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-6438

Keller Grado, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-4497

Kristina Elizabethann Cook, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-4497

Stacy Marie Wagner, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-4497    Fax: 515-241-4405

Nathan Ross Noble, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St., Des Moines, IA 50309 Phone: 515-241-3434

Sara Lynn Uthe, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1221 Pleasant St Ste 170, Des Moines, IA 50309 Phone: 515-241-4300    Fax: 515-241-4359

News Archive

Isotechnika announces CONFIRM1 clinical trial results at TCT 2010 Symposium

Isotechnika Pharma Inc. announces that the results of the CONFIRM1 clinical trial conducted by its medical device partner, Atrium Medical Corporation, were presented by Glenn Van Langenhove, MD, PhD (Middelheim Hospital in Antwerp, Belgium), the principal investigator, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Scientific Symposium in Washington, DC last week.

Quark Pharmaceuticals' QPI-1002 receives orphan drug designation from FDA

Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, announced today that the US FDA has granted orphan drug designation for QPI-1002 (also referred to as "I5NP"), a synthetic siRNA targeting p53 mRNA for the prophylaxis of delayed graft function (DGF) in kidney transplant patients.

CytRx reports $6.3 million net loss for first quarter 2011

CytRx Corporation, a biopharmaceutical company specializing in oncology, today reported financial results for the three months ended March 31, 2011, and provided a business update.

San Francisco judge has slammed the new Bush legislation on abortions as unconstitutional

US federal Judge Phyllis Hamilton has slammed the new Bush legislation on abortions as unconstitutional "This court concludes that the act is unconstitutional because it poses an undue burden on a woman's ability to choose a second trimester abortion; is unconstitutionally vague; and requires a health exception,".

Synta Pharmaceuticals presents preclinical results of STA-9090 at AACR-IASLC Joint Conference

Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical results presented at the AACR-IASLC (American Academy of Cancer Research – International Association for the Study of Lung Cancer) Joint Conference based on work done at Synta and at the Dana-Farber Cancer Institute in Boston showed that STA-9090, a potent, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated potent activity against 100% of all non-small cell lung cancer cell lines tested, including those with EGFR, HER2 or KRAS mutations including the EGFR T790 mutation that is present in roughly 50% of cases of erlotinib or gefitinib resistance.

Read more Medical News

› Verified 2 days ago

• «
• 6
• 7
• 8
• 9
• 10
• 11(current)
• 12
• 13
• 14
• 15
• 16
• »